• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
78,151.45 964.58
( 1.25%)
Global Indices
Nasdaq
52,169.86 -404.11
(-0.77%)
Dow Jones
7,480.34 -74.43
(-0.99%)
Hang Seng
63,887.74 -2,947.80
(-4.41%)
Nikkei 225
10,574.52 2.28
(0.02%)
Forex
USD-INR
96.36 0.10
(0.10%)
EUR-INR
110.37 0.25
(0.23%)
GBP-INR
130.11 0.62
(0.47%)
JPY-INR
0.59 0.00
(0.06%)

EQUITY - MARKET SCREENER

Bliss GVS Pharma Ltd
Industry :  Pharmaceuticals - Indian - Formulations
BSE Code
ISIN Demat
Book Value()
506197
INE416D01022
108.9247686
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
BLISSGVS
52.16
5117.21
EPS(TTM)
Face Value()
Div & Yield %
9.25
1
0.1
 

Nyssa Corporation reports standalone net loss of Rs 12.82 crore in the March 2026 quarter
May 23,2026
Net Loss of Nyssa Corporation reported to Rs 12.82 crore in the quarter ended March 2026 as against net loss of Rs 2.88 crore during the previous quarter ended March 2025. There were no Sales reported in the quarter ended March 2026 as against Rs -0.26 crore during the previous quarter ended March 2025.

For the full year,net loss reported to Rs 12.02 crore in the year ended March 2026 as against net profit of Rs 0.36 crore during the previous year ended March 2025. Sales declined 87.04% to Rs 0.53 crore in the year ended March 2026 as against Rs 4.09 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales0-0.26 100 0.534.09 -87
OPM %01396.15 --2316.98-3.18 -
PBDT-12.42-3.48 -257 -11.480.44 PL
PBT-12.42-3.48 -257 -11.480.44 PL
NP-12.82-2.88 -345 -12.020.36 PL